NEW YORK / Jul 20, 2023 / Business Wire / DocGo Inc. (Nasdaq:DCGO), a leading provider of last-mile mobile health services, is pleased to announce the expansion of its partnership with HealthCare Partners NY, an organization led by physicians that empowers healthcare providers to deliver exceptional healthcare to patients in New York.
This strategic partnership marks a significant milestone in DocGo's mission to offer accessible, high-quality healthcare to all individuals. Building on the success of a pilot program completed in December 2022, DocGo has collaborated closely with HealthCare Partners NY to bridge healthcare gaps and support a value-based model focused on delivering outstanding in-home healthcare services. By keeping patients out of hospitals, this model not only improves outcomes but also reduces costs.
Through this expanded collaboration, several thousand patients will benefit from proactive healthcare services, including annual wellness visits and in-home point of care tests such as diabetic retinal eye exams, bone density tests, A1C screenings, blood pressure control support, and colorectal cancer screenings. By bringing these services directly to patients' homes and increasing accessibility, we aim to facilitate more screenings and enable early disease detection.
"At the heart of the healthcare system are the patients – their needs must always be our top priority," stated Anthony Capone, CEO of DocGo. "By using our advanced technology to deliver proactive care to individuals in their own homes, we enhance the convenience and quality of their healthcare experience. Through our partnership with HealthCare Partners, we are expanding our presence in one of the largest healthcare markets in the country, enabling us to better serve patients and provide them with value-based care that supports their long-term well-being."
This collaboration has the potential to make a profound impact on patients, allowing thousands of individuals to receive proactive care and maintain better health within the comfort of their homes.
"Accessibility remains a significant barrier to health care for many individuals," explained Patrick Adams, CEO of HealthCare Partners NY. "Patients are eager to prioritize their health. By offering essential tests in patients' homes, which are traditionally conducted in healthcare facilities, we are making it easier and more convenient for patients to receive accurate diagnoses, obtain results, and access the treatment they need to lead healthier lives."
ABOUT DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo disrupts the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's proprietary, AI-powered technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.
About HealthCare Partners
HealthCare Partners IPA and HealthCare Partners MSO together compromise our health care delivery system providing enhanced quality care to our members, providers and partners. Active since 1996, HealthCare Partners (HCP) is the largest physician-owned and led IPA in the northeast, serving the five boroughs and Long Island. Our network includes over 4,000 primary care physicians and specialists delivering services to over 185,000 members enrolled in Commercial, Medicare and Medicaid products. Our MSO employs over 200 skilled professional dedicated to ensuring members have access to the highest quality care utilizing healthcare resources with efficiency.
Last Trade: | US$3.51 |
Daily Change: | 0.05 1.45 |
Daily Volume: | 524,355 |
Market Cap: | US$359.140M |
October 09, 2024 September 19, 2024 August 07, 2024 August 05, 2024 August 02, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB